Market Tracker

02/09 6:35am ET

Incyte Corp (NASDAQ:INCY)

70.91
Delayed Data
As of Feb 08
 -0.09 / -0.13%
Today’s Change
64.51
Today|||52-Week Range
133.62
-34.62%
Year-to-Date

Today’s Trading

Previous close71.00
Today’s open69.50
Day’s range65.61 - 71.70
Volume3,376,360
Average volume (3 months)2,115,303
Market cap$13.2B
Dividend yield--
Data as of 02/08/2016

Growth & Valuation

Earnings growth (last year)+48.21%
Earnings growth (this year)+31.10%
Earnings growth (next 5 years)+199.00%
Revenue growth (last year)+44.10%
P/E ratioNM
Price/Sales24.01
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ENDPEndo International P...-3.22-5.98%
BMRNBiomarin Pharmaceuti...-3.67-5.36%
MNKMallinckrodt Plc-4.34-6.25%
RDYDr.Reddy's Laborator...-0.27-0.60%
Data as of 02/08/2016

Financials

Next reporting dateFebruary 11, 2016
EPS forecast (this quarter)$0.09
Annual revenue (last year)$511.5M
Annual profit (last year)-$48.5M
Net profit margin-9.48%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David W. Gryska
Corporate headquarters
Wilmington, Delaware

Forecasts